1. Genentech wants to double its San Francisco footprint — Biotechs with the biggest cash piles — Purdue Pharma wants to pay bonuses even under bankruptcy proceedings — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

PEG

Discussion in 'Halozyme Therapeutics' started by Anonymous, Nov 22, 2014 at 6:30 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What bad news. Wonder when HT will announce PEG is dying too. So now we continue down the road of bad news for even our most promising compound. Now ansnalyst coming in to parcel us up to sell ? How could we have screwed it up so badly? It's terribke
     
  2. Anonymous

    Anonymous Guest

    I like how we are dancing around diabetes news. Ship has sunk. Only is rats remaining. Someone turn off the lights. It's had to believe that we were one on a path to multiple approvals. I'm glad I've got some opportunities elsewhere.
     
  3. Anonymous

    Anonymous Guest

    Corporate raiders upon us! Who gets sold for what?
     
  4. Anonymous

    Anonymous Guest

    I'm sorry you guys aren't happy here, but I like it. If you do work for our company, all this "sky is falling" stuff is weird. Guess what we just signed a deal with JNJ and Hyqvia and Herceptin SC continue to grow. Yes diabetes was a setback but a smaller part of what we do, and I wouldn't completely write it off just yet.
     
  5. Anonymous

    Anonymous Guest

    Oh please. Do you honestly know how disastrous diabetes debacle is/was? We will never recover. Best thing is for them to sell asap
     
  6. Anonymous

    Anonymous Guest

    PEG me please.